
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Letter to the Editor |
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland 20892
A recent "Short Communication" by Toide et al. (1) suggested that CYP1B1 is induced by dioxins and that subjects exposed to dioxins from waste incinerators exhibit a trimodal inducibility distribution. In contrast, the expression of CYP1A1 could not be detected in the same subjects.
The authors analyzed the inducibility of CYP1B1 as ratio of CYP1B1 mRNA expression levels over the TEQ2 concentration of dioxins in plasma. On the basis of the distribution of inducibility in the probit plot analysis, the authors identified three groups of subjects. Those with high and intermediate inducibility showed a significant correlation between CYP1B1 expression and dioxin TEQ concentration. We suggest an alternative interpretation: (a) the distribution of inducibility on the probit plot represents a log-normal and not a trimodal distribution. We propose that the amount of CYP1B1 expression as shown in the authors Fig. 2A, as well as that of the CYP1B1/dioxin ratio in the probit plot of Fig. 2B, suggests a log-normal distribution. In addition, dioxin levels in the general population are known to be log-normally distributed (2) . If log-normal data are not transformed, a probit plot can exhibit an apparent nonlinear pattern (3) . (b) Besides the probit plot analysis, the correlations within the inducibility groups appear to be an artifact of the arithmetical procedure used by the authors. A within-group correlation between the same variables that are used to identify the groups (in this case, CYP1B1 expression and plasma dioxins concentration) will produce spurious positive results.
We report here results on CYP1B1 expression and dioxin TEQs in 71 subjects from Seveso, accidentally exposed to dioxins in 1976 (4)
. TEQ levels ranged between 7.4 and 181.0 pg/g lipid; CYP1B1 mRNA expression ranged between 137 and 148,939 copy number/107 copy number of actin mRNA. CYP1B1 expression was measured in freshly isolated lymphocytes with viability >75% by quantitative reverse transcription-PCR. Overall, there was no correlation between CYP1B1 expression and dioxin TEQ concentration (n = 71; r = 0.08; P = 0.51, Fig. 1iii
). CYP1B1 mRNA, TEQ dioxin concentration, and CYP1B1/TEQ were log-normally distributed (P = 0.47, 0.82, and 0.53, respectively, Shapiro-Wilk test for normal data in log-transformed variables).
|
To illustrate how a spurious correlation between CYP1B1 expression and TEQ dioxin concentration can arise, we generated a series of pairs of independent log-normally distributed random variables and were able to reproduce the probit plots reported in Fig. 1i and ii
. In Fig. 1iv
, we report an example of the correlation results obtained by dividing the observations in three groups based on the simulated plot on the original scale. Although overall, there was no correlation (n = 72; r = -0.05; P = 0.66), in each subgroup, the correlation between simulated CYP1B1 expression and simulated TEQ was positive and statistically significant in the higher and intermediate groups as in Toide et al. (1)
In conclusion, we failed to observe a correlation between dioxins concentration and CYP1B1 expression in the Seveso population. We suggest that the CYP1B1/TEQ ratio follows a log-normal distribution. Additional work is needed to evaluate the role of CYP1B1 in aryl hydrocarbon hydroxylase activity.
Footnotes
1 Seveso Study Group includes Pier Alberto Bertazzi, Angela Pesatori, and Dario Consonni, EPOCA Epidemiology Research Center, University of Milan, Milan, Italy; Neil Caporaso, Genetic Epidemiology Branch, DCEG, National Cancer Institute, NIH, Department of Health and Human Services; Donald Patterson and Larry Needham, Centers for Disease Control, Atlanta, GA; Paolo Mocarelli, Pier Mario Gerthoux, and Paolo Brambilla, Desio Hospital, University of Milano-Bicocca, Italy; Jean Grassman, Scott Masten, and George Lucier, National Institute of Environmental Health Sciences, Research Triangle Park, NC. ![]()
2 The abbreviation used is: TEQ, toxic equivalent. ![]()
Received 4/30/03; revised 6/20/03; accepted 6/23/03.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |